Leukemia and Environmental Chemical Carcinogens
Leukemia—cancer of blood-forming cells—includes both acute and chronic forms with different risk factor profiles. Environmental chemical exposures that damage hematopoietic stem cells or alter bone marrow immune regulation are established leukemia risk factors, with PFAS emerging as a candidate contributor based on mechanistic and occupational epidemiological evidence.
PFAS Effects on Hematopoietic Stem Cells
PFAS accumulate in bone marrow and alter hematopoietic stem cell (HSC) differentiation and self-renewal. HSC exposure to PFAS produces DNA damage, epigenetic reprogramming, and altered transcription factor expression relevant to leukemogenesis. Animal studies show increased bone marrow cell chromosomal aberrations in PFAS-exposed groups consistent with leukemogenic cellular injury.
Epidemiological Evidence
Occupational cohort studies of PFAS-manufacturing workers show elevated risk of non-Hodgkin lymphoma and leukemia subtypes in some analyses. Community studies near PFAS contamination sites report higher childhood leukemia rates in some geographic analyses, though confounding factors complicate interpretation. These signals are not definitive but warrant continued investigation.
Pediatric Oncology Awareness
Pediatric oncologists evaluating childhood leukemia clusters in PFAS-contaminated communities should document environmental exposure history as part of comprehensive case investigation. Geographic clustering of childhood leukemia near PFAS contamination sources warrants ecological assessment to evaluate potential environmental contributors alongside established leukemia risk factors